A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)

Clinical trial NCT02417935 · COMPLETED

Trial details

NCT number: NCT02417935
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathic Pain

Start date: 2015-04-01
Primary completion: 2017-05-13
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.